March 3, 2022 – The University of Maryland School of Medicine’s Institute of Human Virology, a Global Virus Network (GVN) Center of Excellence, physician researchers played a collaborative role in last month’s successful transplant of a genetically-modified pig heart into a patient with terminal heart disease by creating pathogen surveillance strategies and developing an infection prevention strategy for this unprecedent significant medical advancement.

March 2, 2022  – HeartFlow, Inc. has announced that John Farquhar has been appointed President and Chief Executive Officer, effective March 1, 2022.  Farquhar has served as HeartFlow’s President and a member of the board since January 1, 2022. John H. Stevens, M.D. will continue to serve on the Board of Directors as Vice Chair.

March 1, 2022 – To meet the growing industry demand for highly trained clinical professionals specializing in cardiac rhythm management and electrophysiology, Harding University has created the first Master of Science in Cardiac Function and Interventional Technology (CFIT) degree program in the nation.

March 1, 2022 – Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a more than 20% risk of heart attack or stroke over the following 10 years, according to findings from a multi-center study led by preventive cardiologists at UT Southwestern Medical Center.

March 1, 2022 – Scientists have known for years that a person’s risk of cardiovascular disease (CVD) can be lowered with lifestyle changes such as modifying diet, exercise, alcohol and tobacco use.